Thiola 100 MG
Ended Awarded
- Contract number
- 36C24526N0284
- Awardee
-
Travere Therapeutics, Inc. UEI JUBZMHK84S36
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $31,408
Award facts
- Contract value 100% obligated
- $31,408.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92130, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order valued at $31,408.48 to Travere Therapeutics, Inc. for the supply of Thiola 100 mg, a pharmaceutical treatment for cystinuria and kidney disorders. The contract was awarded on January 29, 2026, with an ultimate completion date of February 4, 2026, and operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under Travere's existing Blanket Purchase Agreement with the VA National Acquisition Center, a $25 million single-award contract established September 15, 2021, specifically designated for the procurement of Thiola and Cholbam at pre-negotiated pricing terms.
Travere Therapeutics, a San Diego-based biopharmaceutical company specializing in rare disease therapies affecting kidney and liver function, serves as the prime contractor with no identified subcontractors. The company maintains an established role as a critical supplier to the VA system, having fulfilled pharmaceutical orders across multiple Veterans Integrated Service Networks since 2021. This delivery order supports the VA's mission to provide comprehensive healthcare services to enrolled veterans and reflects the efficiency of the indefinite delivery vehicle structure, which enables predictable procurement and supply chain management for specialized medications essential to veteran healthcare.
Quick answers
Who was awarded contract 36C24526N0284?
36C24526N0284 was awarded to Travere Therapeutics, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on January 29, 2026.
How much is contract 36C24526N0284 worth?
The government has obligated $31,408 on 36C24526N0284.
Is contract 36C24526N0284 an order under another contract?
Yes. 36C24526N0284 is a delivery order under 36F79721D0239, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0284 competed?
The extent of competition for 36C24526N0284 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award